The Toronto Stock Exchange accepts Cangene's normal course issuer bid

NewsGuard 100/100 Score

Cangene Corporation (the "Corporation") announces today that a normal course issuer bid (the "Bid") has been accepted by The Toronto Stock Exchange.

The Corporation intends to purchase for cancellation, during the course of the Bid, up to but not more than 1,500,000 common shares of the Corporation ("Common Shares") representing 2.2% of the outstanding Common Shares on May 25, 2010. As of May 25, 2010, the total number of issued and outstanding Common Shares was 68,246,870 Common Shares. The average daily trading volume for the six months preceding May 25, 2010 was 46,929 Common Shares. Except for block purchases, the daily repurchase restriction during the course of the Bid is 11,732 Common Shares, being 25% of the average daily trading volume.

The Bid will commence on June 1, 2010 and will expire on May 31, 2011. Purchases will be made through the facilities of The Toronto Stock Exchange at prevailing market prices. Any Common Shares purchased by the Corporation under the Bid will be cancelled. During the past 12 months, the Corporation has purchased 1,219,400 Common Shares at an average-weighted price per share of $5.30 pursuant to its previous normal course issuer bid.

The Corporation believes that purchases under the Bid constitute a desirable use of its funds on the basis that recent market prices of the Common Shares of the Corporation do not, and at certain times during the course of the Bid may not, fully reflect the value of its business and future business prospects.

Source:

CANGENE CORPORATION

Posted in:

Tags: , ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.